These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23937559)

  • 1. Novel lectin-modified poly(ethylene-co-vinyl acetate) mucoadhesive nanoparticles of carvedilol: preparation and in vitro optimization using a two-level factorial design.
    Varshosaz J; Moazen E
    Pharm Dev Technol; 2014 Aug; 19(5):605-17. PubMed ID: 23937559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel chitosan-functionalized spherical nanosilica matrix as an oral sustained drug delivery system for poorly water-soluble drug carvedilol.
    Sun L; Wang Y; Jiang T; Zheng X; Zhang J; Sun J; Sun C; Wang S
    ACS Appl Mater Interfaces; 2013 Jan; 5(1):103-13. PubMed ID: 23237208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and evaluation of mucoadhesive buccal films impregnated with carvedilol nanosuspension: a potential approach for delivery of drugs having high first-pass metabolism.
    Rana P; Murthy RS
    Drug Deliv; 2013; 20(5):224-35. PubMed ID: 23651066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucoadhesive chitosan microspheres of carvedilol for nasal administration.
    Patil S; Babbar A; Mathur R; Mishra A; Sawant K
    J Drug Target; 2010 May; 18(4):321-31. PubMed ID: 20199172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of mucoadhesive nanoparticles of poly (methyl vinyl ether-co-maleic anhydride) containing glycyrrhizic acid intended for vaginal administration.
    Aguilar-Rosas I; Alcalá-Alcalá S; Llera-Rojas V; Ganem-Rondero A
    Drug Dev Ind Pharm; 2015; 41(10):1632-9. PubMed ID: 25391332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel carvedilol paediatric nanomicelle formulation: in-vitro characterization and in-vivo evaluation.
    Wegmann M; Parola L; Bertera FM; Taira CA; Cagel M; Buontempo F; Bernabeu E; Höcht C; Chiappetta DA; Moretton MA
    J Pharm Pharmacol; 2017 May; 69(5):544-553. PubMed ID: 27431770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration.
    Venishetty VK; Chede R; Komuravelli R; Adepu L; Sistla R; Diwan PV
    Colloids Surf B Biointerfaces; 2012 Jun; 95():1-9. PubMed ID: 22463845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin.
    Yin Y; Chen D; Qiao M; Lu Z; Hu H
    J Control Release; 2006 Dec; 116(3):337-45. PubMed ID: 17097180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development, optimization and in vitro evaluation of alginate mucoadhesive microspheres of carvedilol for nasal delivery.
    Patil SB; Sawant KK
    J Microencapsul; 2009 Aug; 26(5):432-43. PubMed ID: 18932060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
    Zhang Y; Zhi Z; Li X; Gao J; Song Y
    Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of carvedilol-loaded transdermal drug delivery system: In-vitro and in-vivo characterization study.
    Kshirsagar SJ; Bhalekar MR; Mohapatra SK
    Drug Dev Ind Pharm; 2012 Dec; 38(12):1530-7. PubMed ID: 22356303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(ethylene-co-vinyl acetate) copolymer matrix for delivery of chlorhexidine and acyclovir drugs for use in the oral environment: effect of drug combination, copolymer composition and coating on the drug release rate.
    Tallury P; Alimohammadi N; Kalachandra S
    Dent Mater; 2007 Apr; 23(4):404-9. PubMed ID: 16556460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, in vitro evaluation and statistical optimization of carvedilol-loaded solid lipid nanoparticles for lymphatic absorption via oral administration.
    Shah MK; Madan P; Lin S
    Pharm Dev Technol; 2014 Jun; 19(4):475-85. PubMed ID: 23697916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubility enhancement and physicochemical characterization of carvedilol solid dispersion with Gelucire 50/13.
    Potluri RH; Bandari S; Jukanti R; Veerareddy PR
    Arch Pharm Res; 2011 Jan; 34(1):51-7. PubMed ID: 21468915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled delivery of carvedilol nanosuspension from osmotic pump capsule: in vitro and in vivo evaluation.
    Liu D; Yu S; Zhu Z; Lyu C; Bai C; Ge H; Yang X; Pan W
    Int J Pharm; 2014 Nov; 475(1-2):496-503. PubMed ID: 25219321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective in-vivo utilization of lipid-based nanoparticles as drug carrier for carvedilol phosphate.
    Chakraborty S; Shukla D; Vuddanda PR; Mishra B; Singh S
    J Pharm Pharmacol; 2011 Jun; 63(6):774-9. PubMed ID: 21585374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model.
    Beck-Broichsitter M; Gauss J; Packhaeuser CB; Lahnstein K; Schmehl T; Seeger W; Kissel T; Gessler T
    Int J Pharm; 2009 Feb; 367(1-2):169-78. PubMed ID: 18848609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHX) based nanoparticles for targeted cancer therapy.
    Kılıçay E; Demirbilek M; Türk M; Güven E; Hazer B; Denkbas EB
    Eur J Pharm Sci; 2011 Oct; 44(3):310-20. PubMed ID: 21884788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amorphous amphiphilic P(3HV-co-4HB)-b-mPEG block copolymer synthesized from bacterial copolyester via melt transesterification: nanoparticle preparation, cisplatin-loading for cancer therapy and in vitro evaluation.
    Shah M; Ullah N; Choi MH; Kim MO; Yoon SC
    Eur J Pharm Biopharm; 2012 Apr; 80(3):518-27. PubMed ID: 22178562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.